Advances in collating and using trial data

Author:

Crowe Brenda1,Wang Wei2,Nilsson Mary E3

Affiliation:

1. Brenda Crowe works as a Statistical Research Advisor at Eli Lilly and Company (IN, USA). She obtained a PhD in statistics from the University of Toronto (ON, Canada) in 1997. She currently leads a Safety Analytics team that seeks to improve safety signal detection and evaluation.

2. Wei Wang works as a Statistician with the Safety Analytics team at Eli Lilly and Company. She obtained a MD from the Capital University of Medical Sciences (Beijing, China) and a MPH from the University of Hawaii (USA). She has 13 years of experience working in drug development. Her research interests include analytical methods on safety data in clinical trials, visual analytics and meta-analysis.

3. Mary E Nilsson works as a Statistician at Eli Lilly and Company. She obtained a Master’s in statistics from Iowa State University (USA) in 1989. Her experience has primarily been in Phase II–IV clinical trials. Her primary interests include safety analytics, statistical analysis planning, and collection and analysis of suicide-related events.

Publisher

Future Science Ltd

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Interdisciplinary Safety Evaluation for Learning and Decision-Making;Therapeutic Innovation & Regulatory Science;2021-03-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3